Literature DB >> 19136055

Increased IgG4 levels in children with autism disorder.

Amanda Enstrom1, Paula Krakowiak, Charity Onore, Isaac N Pessah, Irva Hertz-Picciotto, Robin L Hansen, Judy A Van de Water, Paul Ashwood.   

Abstract

Accumulating evidence indicates that immune dysfunction is associated with autism disorders in a significant subset of children. Previous reports have shown abnormal immunoglobulin (Ig) levels, including an increased presence of autoreactive antibodies in the circulation of individuals with autism. As IgG is the predominant antibody isotype in circulation, we expected that an altered immune response could result in an abnormal IgG subclass profile in children with autism. We examined circulating plasma levels of IgG1, IgG2, IgG3, and IgG4 in 241 children from the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, a large epidemiologic case-control investigation, including 114 children who meet full criteria for autism disorder (AU), 96 typically developing control children (TD) from a randomly selected sample of the general population, and 31 children with developmental delays (DD). We report significantly increased levels of the IgG4 subclass in children with AU compared with TD control children (p=0.016) and compared with DD controls (p=0.041). These results may suggest an underlying immunological abnormality in AU subjects resulting in elevated IgG4 production. Further investigation is necessary to elucidate the relationship between immunological findings and behavioral impairments in autism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19136055      PMCID: PMC2696343          DOI: 10.1016/j.bbi.2008.12.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  59 in total

1.  Immune reactivity to mite allergens in nonatopic subjects: immune deviation or immune ignorance.

Authors:  R C Aalberse; E Vermeulen
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

Review 2.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

4.  Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder.

Authors:  Harumi Jyonouchi; Sining Sun; Nanae Itokazu
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

5.  Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism.

Authors:  J Croonenberghs; A Wauters; K Devreese; R Verkerk; S Scharpe; E Bosmans; B Egyed; D Deboutte; M Maes
Journal:  Psychol Med       Date:  2002-11       Impact factor: 7.723

6.  [Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group].

Authors:  G V Kozlovskaia; T P Kliushnik; A V Goriunova; I L Turkova; M A Kalinina; N S Sergienko
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2000

Review 7.  Genetic and immunologic considerations in autism.

Authors:  Elena Korvatska; Judy Van de Water; Thomas F Anders; M Eric Gershwin
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

8.  Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.

Authors:  A Vojdani; A W Campbell; E Anyanwu; A Kashanian; K Bock; E Vojdani
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

9.  Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.

Authors:  Naoko Narita; Michiko Kato; Mami Tazoe; Kaoru Miyazaki; Masaaki Narita; Nobuo Okado
Journal:  Pediatr Res       Date:  2002-10       Impact factor: 3.756

10.  Prevalence of autism in a US metropolitan area.

Authors:  Marshalyn Yeargin-Allsopp; Catherine Rice; Tanya Karapurkar; Nancy Doernberg; Coleen Boyle; Catherine Murphy
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

View more
  45 in total

1.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2010-11-20       Impact factor: 3.478

2.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

Review 3.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

Review 4.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

5.  C57BL/6J bone marrow transplant increases sociability in BTBR T+ Itpr3tf/J mice.

Authors:  Jared J Schwartzer; Charity E Onore; Destanie Rose; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2016-05-26       Impact factor: 7.217

Review 6.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 7.  Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder.

Authors:  Helen E Vuong; Elaine Y Hsiao
Journal:  Biol Psychiatry       Date:  2016-08-26       Impact factor: 13.382

8.  Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic.

Authors:  Aisha S Dickerson; Mohammad H Rahbar; Amanda V Bakian; Deborah A Bilder; Rebecca A Harrington; Sydney Pettygrove; Russell S Kirby; Maureen S Durkin; Inkyu Han; Lemuel A Moyé; Deborah A Pearson; Martha Slay Wingate; Walter M Zahorodny
Journal:  Environ Monit Assess       Date:  2016-06-14       Impact factor: 2.513

9.  Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.

Authors:  Anthony R Torres; Jonna B Westover; Cole Gibbons; Randall C Johnson; David C Ward
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

10.  Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, lead or mercury.

Authors:  Aisha S Dickerson; Mohammad H Rahbar; Inkyu Han; Amanda V Bakian; Deborah A Bilder; Rebecca A Harrington; Sydney Pettygrove; Maureen Durkin; Russell S Kirby; Martha Slay Wingate; Lin Hui Tian; Walter M Zahorodny; Deborah A Pearson; Lemuel A Moyé; Jon Baio
Journal:  Sci Total Environ       Date:  2015-07-25       Impact factor: 7.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.